Bumepidil

This classification denotes a vasodilating agent with the molecular formula C12H17N5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9FNZ7TFY4R, chemically known as 8-tert-butyl-7,8-dihydro-5-methyl-6h-pyrrolo(3,2-e)-s-triazolo(1,5-a)pyrimidine but generally known as bumepidil, which bears US NIH Compound Identifier 68813. European Medicines Agency schedules Bumepidil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05970MIG. The term BUMEPIDIL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 35, No. 5 1981, List 21). BUMEPIDIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule bumepidil under HS 29335995 and SITC 51576. As of Q4 2014, BUMEPIDIL remains the US FDA Preferred Term for this commodity. Bumepidil bears US NLM identifiers UMLS ID C0107460 and NCI Concept Code C73108. SMILES: CC1=NC2=NC=NN2C3=C1CCN3C(C)(C)C.